ENHERTU vs IDARUBICIN HYDROCHLORIDE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. ENHERTU and IDARUBICIN HYDROCHLORIDE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ENHERTU	IDARUBICIN HYDROCHLORIDE
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	FAM-TRASTUZUMAB DERUXTECAN-NXKI	IDARUBICIN HYDROCHLORIDE
Manufacturer	Daiichi Sankyo Inc	Hikma
Dosage forms	Injectable	Injectable
Drug class	—	Anthracycline Topoisomerase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Breast Neoplasms, Gastrointestinal Neoplasms	Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia

enhertu idarubicin hydrochloride

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

FAM-TRASTUZUMAB DERUXTECAN-NXKI

IDARUBICIN HYDROCHLORIDE

Manufacturer

Daiichi Sankyo Inc

Hikma

Dosage forms

Injectable

Drug class

—

Anthracycline Topoisomerase Inhibitor

Boxed warning

Treats

Breast Neoplasms, Gastrointestinal Neoplasms

Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia

Frequently asked questions

What is the difference between Enhertu and Idarubicin Hydrochloride?

Enhertu contains Fam-Trastuzumab Deruxtecan-Nxki, while Idarubicin Hydrochloride contains Idarubicin Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.